Abstract
Infants with alloimmune neonatal neutropenia (ANN) may be at risk of life-threatening infection. Various modalities of treatment have been attempted but with differing results. We describe a case treated with rHuG-CSF. The use of rHuG-CSF should be considered in children with ANN especially when associated with life-threatening infection.
MeSH terms
-
Female
-
Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use
-
Hematopoietic Cell Growth Factors / therapeutic use*
-
Humans
-
Infant, Newborn
-
Infant, Newborn, Diseases / drug therapy
-
Infant, Newborn, Diseases / immunology*
-
Neutropenia / drug therapy
-
Neutropenia / immunology*
-
Recombinant Proteins
-
Treatment Outcome
Substances
-
Hematopoietic Cell Growth Factors
-
Recombinant Proteins
-
Granulocyte-Macrophage Colony-Stimulating Factor